Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Inclusion Criteria

• •1. The age is 18-90 years old (including 18 and 90 years old);
• •2. The subjects knew about the experiment and signed the informed consent voluntarily;
• •3. The subjects complicated with tumor diseases and atherosclerotic plaques;
• •4. The subjects received regular PD-1 inhibitor treatment;
• •5. The subjects had ultrasound images of atherosclerotic plaques before- and after- or during PD-1 blockade treatment at the two different timepoints;
• •6. The subjects received regular treatments of PD-1 inhibitor during the two timepoints of artery ultrasound examinations;
• •7. The subjects who had ultrasound images before the initiation of first-dose PD-1 inhibitor, the interval between these two timepoints should be restricted within 1 month;
• •8. The subjects who had ultrasound images after 3 months of PD-1 inhibitor treatment.